within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BA02_Procainamide;

model Procainamide_1
  extends Pharmacolibrary.Drugs.ATC.C.C01BA02_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01BA02_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Procainamide is a Class Ia antiarrhythmic drug used to treat and prevent various types of cardiac arrhythmias, including ventricular and supraventricular arrhythmias. It acts by blocking sodium channels in the heart. Procainamide is approved and still in clinical use, though less frequently than in the past due to alternative therapies and concerns regarding side effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult healthy volunteers after oral administration.</p><h4>References</h4><ol><li><p>Karlsson, E (1978). Clinical pharmacokinetics of procainamide. <i>Clinical pharmacokinetics</i> 3(2) 97–107. DOI:<a href=\"https://doi.org/10.2165/00003088-197803020-00001\">10.2165/00003088-197803020-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/346289/\">https://pubmed.ncbi.nlm.nih.gov/346289</a></p></li><li><p>Martin, DE, et al., &amp; Cascio, W (1996). Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide. <i>Journal of clinical pharmacology</i> 36(1) 85–91. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1996.tb04156.x\">10.1002/j.1552-4604.1996.tb04156.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8932548/\">https://pubmed.ncbi.nlm.nih.gov/8932548</a></p></li><li><p>Tilstone, WJ, et al., &amp; Lawrie, TD (1978). The pharmacokinetics of slow-release procainamide. <i>European journal of clinical pharmacology</i> 14(4) 261–265. DOI:<a href=\"https://doi.org/10.1007/BF00560459\">10.1007/BF00560459</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/729620/\">https://pubmed.ncbi.nlm.nih.gov/729620</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Procainamide_1;
